News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Proxima Therapeutics Release: First Data On GliaSite Radiation Therapy System As Primary Treatment For Metastatic Brain Cancer Presented At Radiation Oncology Meeting


10/19/2005 5:11:45 PM

Proxima Therapeutics, Inc. today announced encouraging results of a post-market study on the GliaSite Radiation Therapy System as a first-line treatment for single resected brain metastasis. Each year, more than 150,000 people are diagnosed with metastatic brain tumors--tumors that first exist in other parts of the body and then spread to the brain. Details from this multi-center study were presented at the Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) taking place in Atlanta, October 3-7, in a poster discussion entitled, "Interim Results of a Phase II Study of Resection and GliaSite Brachytherapy for a Single Brain Metastasis," presented by Dr. Lisa Rogers of Henry Ford Hospital in Detroit.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES